FEops provides medical device companies, physicians, and medical specialists with computer simulations that offer unique insights, improving patient safety and speeding up R&D processes. Their cardiac imaging technology generates data-driven insights to improve transcatheter valve procedures based on personalized computer simulations, enabling healthcare professionals to improve both procedure efficiency and clinical outcomes. The company's cutting-edge technology transforms cardiac images into digital twins, virtual copies of the heart or its substructures, and with AI-enabled anatomical analyses, FEops aims to enhance and improve structural heart disease management from patient selection to patient follow-up. The CE-marked and FDA-cleared FEops HEARTguide technology empowers healthcare professionals and Medtech companies to bring superior products to the market faster than ever before.